Skip to main content

Table 3 Lifetime incidence of diabetes-related complications and depression episodes

From: The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation

Results per 2,000,000 people

Current practice (CP)

Policy 1a

Policy 2b

Policy 3c

Policy 1 — CP

Policy 2 — CP

Policy 3 — CP

Number of microvascular complications

 Blindness

116,237

114,360

115,070

113,287

−1,877

−1,167

−2,950

 Renal failure

68,633

66,840

66,890

66,150

−1,793

−1,743

−2,483

 Diabetic ulcer

69,320

68,803

68,633

67,920

−517

−687

−1,400

 Amputation

87,017

85,303

85,450

84,560

−1,713

−1,567

−2,457

 Total

341,207

335,306

336,043

331,917

−5,900

−5,164

−9,290

Number of macrovascular complications

 IHD

277,880

275,627

276,923

274,883

−2,253

−957

−2,997

 MI

377,417

374,227

374,190

373,437

−3,190

−3,227

−3,980

 Stroke

274,880

273,010

272,980

271,650

−1,870

−1,900

−3,230

 CHF

221,130

219,640

219,250

218,587

−1,490

−1,880

−2,543

 Total

1,151,307

1,142,504

1,143,343

1,138,557

−8,803

−7,964

−12,750

Number depression episodes (1,000)

 Total number

15,517

15,598

15,563

15,605

80

46

88

 Identified

7,937

7,983

13,547

13,588

46

5,610

5,650

 Unidentified

7,580

7,615

2,016

2,018

35

−5,564

−5,562

  1. CP Current practice, IHD Ischaemic heart disease, MI Myocardial infarction, CHF Congestive heart failure. aPolicy 1 = collaborative care; bPolicy 2 = opportunistic screening; cPolicy 3 = both collaborative care and opportunistic screening